Obagi Medical Income Statement
View: Annual
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 102.7 | 78.0 | 64.9 |
| Cost of Goods Sold | 18.0 | 13.5 | 11.6 |
| Gross Profit | 84.6 | 64.5 | 53.4 |
| Gross Profit Margin | 82.4% | 82.7% | 82.2% |
| SG&A Expense | 54.1 | 44.0 | 30.2 |
| Depreciation & Amortization | 2.8 | 2.8 | 2.1 |
| Operating Income | 27.7 | 17.8 | 21.1 |
| Operating Margin | 27.0% | 22.8% | 32.5% |
| Nonoperating Income | 0.2 | 0.0 | 0.1 |
| Nonoperating Expenses | 2.4 | 8.2 | 6.2 |
| Income Before Taxes | 25.5 | 9.6 | 15.0 |
| Income Taxes | 10.3 | 3.5 | 6.0 |
| Net Income After Taxes | 15.2 | 6.1 | 9.0 |
| Continuing Operations | 15.2 | 6.1 | 9.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 15.2 | 6.1 | 9.0 |
| Total Net Income | 15.2 | 6.1 | 9.0 |
| Net Profit Margin | 14.8% | 7.8% | 13.8% |
| Diluted EPS from Total Net Income ($) | 0.69 | 0.34 | 0.50 |
| Dividends per Share | -- | -- | -- |






